{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Michael Urbaniak"}, {"accession": "MS:1000589", "name": "contact email", "value": "m.urbaniak@lancaster.ac.uk"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Lancaster University"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Ian H Gilbert"}, {"accession": "MS:1000589", "name": "contact email", "value": "i.h.gilbert@dundee.ac.uk"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, United Kingdom"}]}], "datasetFiles": [{"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009711/MU-BA02.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009711/MU-BA05.raw"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009711/MaxQuant-txt.zip"}, {"accession": "PRIDE:0000403", "name": "Associated file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009711/LinfantumJPCM5_AnnotProt_V24.fasta"}], "description": "We describe the development of a novel anti-leishmanial drug-like chemical series based on a pyrazolopyrimidine scaffold. The leading compound  is efficacious in a mouse model of visceral leishmaniasis, and has suitable physicochemical, pharmacokinetic and toxicological properties for further development and has been declared a preclinical candidate. Detailed mode of action studies indicate that compounds from this series act principally by inhibiting the parasite protein kinases.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2018/11/PXD009711"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD009711"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD009711"}], "instruments": [{"accession": "MS:1001742", "name": "LTQ Orbitrap Velos"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Chemical proteomics, Leishmania"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biomedical"}], "modifications": [{"accession": "MOD:00398", "name": "carbamoylated residue"}, {"accession": "MOD:00425", "name": "monohydroxylated residue"}, {"accession": "MOD:00394", "name": "acetylated residue"}], "publications": [{"terms": [{"accession": "PRIDE:0000432", "name": "Dataset with its publication pending"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Leishmania donovani"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "5661"}]}], "title": "Mode of action studies for a novel anti-leishmania compound"}